Nitric oxide and mitochondria in metabolic syndrome

Larisa Litvinova, Dmitriy N. Atochin, Nikolai Fattakhov, Mariia Vasilenko, Pavel Zatolokin, Elena Kirienkova

Research output: Contribution to journalReview article

43 Citations (Scopus)

Abstract

Metabolic syndrome (MS) is a cluster of metabolic disorders that collectively increase the risk of cardiovascular disease. Nitric oxide (NO) plays a crucial role in the pathogeneses of MS components and is involved in different mitochondrial signaling pathways that control respiration and apoptosis. The present review summarizes the recent information regarding the interrelations of mitochondria and NO in MS. Changes in the activities of different NO synthase isoforms lead to the formation of metabolic disorders and therefore are highlighted here. Reduced endothelial NOS activity and NO bioavailability, as the main factors underlying the endothelial dysfunction that occurs in MS, are discussed in this review in relation to mitochondrial dysfunction. We also focus on potential therapeutic strategies involving NO signaling pathways that can be used to treat patients with metabolic disorders associated with mitochondrial dysfunction. The article may help researchers develop new approaches for the diagnosis, prevention and treatment of MS.

Original languageEnglish
Article number20
JournalFrontiers in Physiology
Volume6
Issue numberFEB
DOIs
Publication statusPublished - 2015
Externally publishedYes

    Fingerprint

Keywords

  • Metabolic syndrome
  • Mitochondrial dysfunction
  • Mitochondrial nitric oxide synthase
  • Nitric oxide
  • Nitric oxide synthase
  • Nitric oxide synthase type I
  • Nitric oxide synthase type II
  • Oxide synthase type III

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Litvinova, L., Atochin, D. N., Fattakhov, N., Vasilenko, M., Zatolokin, P., & Kirienkova, E. (2015). Nitric oxide and mitochondria in metabolic syndrome. Frontiers in Physiology, 6(FEB), [20]. https://doi.org/10.3389/fphys.2015.00020